China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 54.0% in September

Key Points

• Short interest in China SXT Pharmaceuticals, Inc. decreased by 54.0% in September, dropping from 316,200 shares to 145,300 shares.
• Despite a recent upgrade from "sell" to "hold" by Wall Street Zen, the consensus rating remains at "Sell", with one analyst maintaining a sell rating.
• The company's stock opened at $1.44 and is trading between a 12-month low of $0.95 and a high of $7.84.

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC - Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totaling 145,300 shares, a decline of 54.0% from the September 15th total of 316,200 shares. Based on an average daily trading volume, of 306,100 shares, the short-interest ratio is presently 0.5 days. Based on an average daily trading volume, of 306,100 shares, the short-interest ratio is presently 0.5 days.

Analyst Upgrades and Downgrades

SXTC has been the subject of several recent analyst reports. Wall Street Zen raised shares of China SXT Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Saturday, August 2nd. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of China SXT Pharmaceuticals in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, China SXT Pharmaceuticals presently has a consensus rating of "Sell".

China SXT Pharmaceuticals Trading Up 1.3%

China SXT Pharmaceuticals stock opened at $1.44 on Monday. China SXT Pharmaceuticals has a twelve month low of $0.95 and a twelve month high of $7.84. The company has a current ratio of 3.54, a quick ratio of 3.40 and a debt-to-equity ratio of 0.01. The company has a 50 day moving average of $1.61 and a 200-day moving average of $1.74.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.